Medical Data Collection for the Evaluation of Radiofrequency Ablation and Cement Augmentation for the Treatment of Secondary Metastases to the Spine

Recruiting

• Conditions: Metastatic Malignant Neoplasm in the Spine
• Interventions: Other: Electronic Health Record Review

• Registration Number: NCT04751422
• Lead Sponsor: M.D. Anderson Cancer Center

Brief Summary

This study collects data on the use of radiofrequency ablation and cement augmentation for the treatment of cancer that has spread to the spine (metastases to the spine). Radiofrequency ablation with cement augmentation is a useful approach for the treatment of secondary metastasis to the spine. Information collected in this study may help doctors to learn the effectiveness of this therapy, and may help to evaluate optimal technique, appropriate patient selection, and management of complications.

Detailed Description

PRIMARY OBJECTIVE:

I. To evaluate the use of radiofrequency ablation and cement augmentation for the treatment of secondary metastases to the spine.

OUTLINE:

Patients' medical data is collected retrospectively.

Study Timeline

• Study Start: 2020-11-13
• Study First Submitted: 2021-02-08
• Study First Submitted QC: 2021-02-08
• Study First Posted: 2021-02-12
• Status Verified: 2023-04
• Last Update Submitted: 2023-04-10
• Last Update Posted: 2023-04-12
• Primary Completion: 2023-09-30
• Study Completion: 2023-09-30

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• Patients who underwent radiofrequency ablation with cement augmentation at the Department of Interventional Radiology at MD Anderson Cancer Center (MDACC) between 1/1/2017 and 9/26/2020

Exclusion Criteria

• None

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Observational (data collection)	Electronic Health Record Review	Patients' medical data is collected retrospectively.

Primary Outcome Measures

Name	Time	Method
Technical success	Up to 3 years	Results will be compared with data available from other published literature.
Complication rates	Up to 3 years	Results will be compared with data available from other published literature.
Clinical success	Up to 3 years	Results will be compared with data available from other published literature.

Trial Locations

Locations (1)

M D Anderson Cancer Center; 🇺🇸 Houston, Texas, United States